tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MLLCF Stock Latest News

Molecular Partners backs FY24 total expenses view of of CHF 65M-CHF 70M
The FlyMolecular Partners backs FY24 total expenses view of of CHF 65M-CHF 70M
3M ago
MOLN
Molecular Partners, Orano Med announce presentation of MP0712 data
PremiumThe Fly
Molecular Partners, Orano Med announce presentation of MP0712 data
3M ago
NVS
MOLN
Molecular Partners expands 212Pb co-development agreement with Orano Med
PremiumThe Fly
Molecular Partners expands 212Pb co-development agreement with Orano Med
3M ago
MOLN
Molecular Partners AG (ADR) trading resumes
PremiumThe Fly
Molecular Partners AG (ADR) trading resumes
4M ago
MOLN
Molecular Partners AG (ADR) trading halted, volatility trading pause
PremiumThe Fly
Molecular Partners AG (ADR) trading halted, volatility trading pause
4M ago
MOLN
Molecular Partners price target raised to CHF 4.50 from CHF 3.70 at JPMorgan
PremiumThe FlyMolecular Partners price target raised to CHF 4.50 from CHF 3.70 at JPMorgan
5M ago
MOLN
Molecular Partners AG (ADR) trading resumes
Premium
The Fly
Molecular Partners AG (ADR) trading resumes
6M ago
MOLN
Molecular Partners AG (ADR) trading halted, volatility trading pause
Premium
The Fly
Molecular Partners AG (ADR) trading halted, volatility trading pause
6M ago
MOLN
Molecular Partners AG (ADR) trading resumes
PremiumThe Fly
Molecular Partners AG (ADR) trading resumes
7M ago
MOLN
Molecular Partners AG (ADR) trading halted, volatility trading pause
PremiumThe Fly
Molecular Partners AG (ADR) trading halted, volatility trading pause
7M ago
MOLN
Molecular Partners announces preclinical data from MP0621 trial
PremiumThe Fly
Molecular Partners announces preclinical data from MP0621 trial
7M ago
MOLN
Molecular Partners, Orano Med present MP0712 data at SNMMI
PremiumThe Fly
Molecular Partners, Orano Med present MP0712 data at SNMMI
7M ago
MOLN
Molecular Partners presents data from completed Phase 1 trial of MP0317
PremiumThe FlyMolecular Partners presents data from completed Phase 1 trial of MP0317
8M ago
MOLN
Molecular Partners, Orano Med enter pact to develop Radio-DARPin therapeutics
Premium
The Fly
Molecular Partners, Orano Med enter pact to develop Radio-DARPin therapeutics
1y ago
MOLN
Molecular presents data from dosing cohorts of Phase 1/2a trial of MP0533
Premium
The Fly
Molecular presents data from dosing cohorts of Phase 1/2a trial of MP0533
1y ago
MOLN
Molecular Partners price target lowered by CHF 2 at JPMorgan
PremiumThe Fly
Molecular Partners price target lowered by CHF 2 at JPMorgan
1y ago
MOLN
Molecular Partners price target lowered by $2.10 at JPMorgan, here’s why
PremiumThe Fly
Molecular Partners price target lowered by $2.10 at JPMorgan, here’s why
1y ago
MOLN
Molecular Partners present updated data from Phase 1 trial of MP0317
PremiumThe Fly
Molecular Partners present updated data from Phase 1 trial of MP0317
1y ago
MOLN
Molecular Partners sees FY23 total expenses of CHF 65-70
PremiumThe Fly
Molecular Partners sees FY23 total expenses of CHF 65-70
1y ago
MOLN
Molecular Partners: Continued validation seen across DARPin portfolio
PremiumThe FlyMolecular Partners: Continued validation seen across DARPin portfolio
1y ago
MOLN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >